Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progressive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06329401
What this trial is testing

A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

Who this might be right for
Pulmonary FibrosisProgressive Pulmonary FibrosisPulmonary Fibrosis Secondary to Systemic Sclerosis+7 more
Avalyn Pharma Inc. 375
Large-scale testing (Phase 3)Active Not RecruitingNCT04211337
What this trial is testing

Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer

Who this might be right for
Medullary Thyroid Cancer
Loxo Oncology, Inc. 291
Not applicableStudy completedNCT04120675
What this trial is testing

Efficacy of Early Harvest Olive Oil in Cognition of Primary (PPMS) or Secondary (SPMS) Progressive Multiple Sclerosis

Who this might be right for
Progressive Multiple Sclerosis
Aristotle University Of Thessaloniki 30
Large-scale testing (Phase 3)Active Not RecruitingNCT02319837
What this trial is testing

Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)

Who this might be right for
Hormone Sensitive Prostate CancerProstate CancerCancer of the Prostate
Pfizer 1,068
Testing effectiveness (Phase 2)Looking for participantsNCT07429240
What this trial is testing

PBGENE-DMD Phase 1/2a Safety and Preliminary Efficacy Study in Duchenne Muscular Dystrophy (FUNCTION-DMD)

Who this might be right for
Duchenne Muscular Dystrophy With Mutations Amenable to PBGENE-DMD
Precision BioSciences, Inc. 18
Not applicableUnknownNCT05396976
What this trial is testing

The Effect of Yoga and Progressive Muscle Relaxation Exercise Practices on Premenstrual Syndrome

Who this might be right for
Premenstrual Syndrome
Eastern Mediterranean University 72
Testing effectiveness (Phase 2)Study completedNCT00943449
What this trial is testing

4SC-201 (Resminostat) and Sorafenib in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
4SC AG 57
Testing effectiveness (Phase 2)Study completedNCT00278915
What this trial is testing

Faslodex in McCune-Albright Syndrome

Who this might be right for
Puberty, PrecociousMcCune-Albright Syndrome
AstraZeneca 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07151326
What this trial is testing

Cabozantinib for Progressive HCC Post-first-line Immuno-oncologic Combination Therapy

Who this might be right for
Hepatocellular Carcinoma (HCC)
National Health Research Institutes, Taiwan 60
Very early researchActive Not RecruitingNCT03970226
What this trial is testing

Tocilizumab in Children With ACP

Who this might be right for
Adamantinomatous Craniopharyngioma
University of Colorado, Denver 9
Not applicableNo Longer AvailableNCT02094222
What this trial is testing

Expanded Access Protocol for an Intermediate Size Population - RAVICTI for Byler Disease

Who this might be right for
Byler Disease
Robert Squires, Jr.
Testing effectiveness (Phase 2)Looking for participantsNCT05828069
What this trial is testing

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

Who this might be right for
Recurrent Langerhans Cell HistiocytosisRefractory Langerhans Cell Histiocytosis
National Cancer Institute (NCI) 48
Not applicableActive Not RecruitingNCT06413602
What this trial is testing

The Synergistic Effects of AIH and FES in Persons With MS

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary Progressive
Shirley Ryan AbilityLab 40
Not applicableStudy completedNCT06492577
What this trial is testing

Combined Pulmonary Rehabilitation and PMR for Long-Term COVID-19 Symptoms: A RCT

Who this might be right for
Long Covid19Pulmonary RehabilitationProgressive Muscle Relaxation
Spitalul Clinic de Boli Infecțioase și Pneumoftiziologie Dr. Victor Babeș Timișoara 61
Large-scale testing (Phase 3)Active Not RecruitingNCT06238622
What this trial is testing

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

Who this might be right for
Idiopathic Pulmonary FibrosisProgressive Pulmonary Fibrosis
Boehringer Ingelheim 1,666
Not applicableStudy completedNCT05663853
What this trial is testing

An Observational Biomarker Study in Multiple Sclerosis (MS) Patients

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Secondary Progressive
LAPIX Therapeutics Inc. 137
Not applicableStudy completedNCT00342602
What this trial is testing

Genetics of Progressive Multifocal Leukoencephalopathy and Acquired Immunodeficiency Syndrome

Who this might be right for
PMLAIDS
National Cancer Institute (NCI) 450
Testing effectiveness (Phase 2)Ended earlyNCT01122901
What this trial is testing

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Recurrent or Progressive Glioblastoma

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more
National Cancer Institute (NCI) 47
Not applicableStudy completedNCT01604590
What this trial is testing

Imaging Biomarkers of Tissue Microstructure and Vasculature as Predictors of Glioblastoma Multiforme

Who this might be right for
Glioblastoma
Medical University of South Carolina 13
Testing effectiveness (Phase 2)Ended earlyNCT02983097
What this trial is testing

Therapy of Non-Hodgkin-Lymphoma by Combination of Lenalidomide + Rituximab, Dexa, High-dose ARA-C and CisP

Who this might be right for
Diffuse Large B-cell Lymphoma (DLBCL)Follicular Lymphoma Grade III (FL III°)Mantle Cell Lymphoma (MCL), Blastoid Variant+2 more
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 34
Next Page